Jack Wallace
Stock Analyst
(n/a)
# 3,025
Out of 4,648 analysts
26
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Jack Wallace
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
VEEV Veeva Systems | Maintains: Buy | $233 → $249 | $212.19 | +17.35% | 4 | Oct 1, 2024 | |
WW WW International | Maintains: Buy | $12 → $6 | $1.16 | +416.31% | 3 | Aug 2, 2024 | |
RCM R1 RCM | Maintains: Buy | $17 → $15 | $14.26 | +5.19% | 4 | Apr 5, 2024 | |
HIMS Hims & Hers Health | Maintains: Buy | $15 → $17 | $20.81 | -18.31% | 4 | Feb 27, 2024 | |
HCAT Health Catalyst | Upgrades: Buy | $14 | $7.61 | +84.09% | 3 | Jan 26, 2024 | |
IQV IQVIA Holdings | Maintains: Buy | $253 → $220 | $208.05 | +5.75% | 1 | Nov 3, 2023 | |
PHR Phreesia | Maintains: Buy | $35 → $40 | $18.40 | +117.39% | 5 | Mar 29, 2023 | |
AMWL American Well | Reiterates: Buy | $100 | $9.23 | +983.22% | 1 | Mar 15, 2023 | |
PINC Premier | Initiates: Neutral | n/a | $20.06 | - | 1 | Apr 14, 2022 |
Veeva Systems
Oct 1, 2024
Maintains: Buy
Price Target: $233 → $249
Current: $212.19
Upside: +17.35%
WW International
Aug 2, 2024
Maintains: Buy
Price Target: $12 → $6
Current: $1.16
Upside: +416.31%
R1 RCM
Apr 5, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $14.26
Upside: +5.19%
Hims & Hers Health
Feb 27, 2024
Maintains: Buy
Price Target: $15 → $17
Current: $20.81
Upside: -18.31%
Health Catalyst
Jan 26, 2024
Upgrades: Buy
Price Target: $14
Current: $7.61
Upside: +84.09%
IQVIA Holdings
Nov 3, 2023
Maintains: Buy
Price Target: $253 → $220
Current: $208.05
Upside: +5.75%
Phreesia
Mar 29, 2023
Maintains: Buy
Price Target: $35 → $40
Current: $18.40
Upside: +117.39%
American Well
Mar 15, 2023
Reiterates: Buy
Price Target: $100
Current: $9.23
Upside: +983.22%
Premier
Apr 14, 2022
Initiates: Neutral
Price Target: n/a
Current: $20.06
Upside: -